| Literature DB >> 29387467 |
Ali Valika1, Maria Rosa Costanzo1.
Abstract
Sleep-disordered breathing is common in heart failure patients and is associated with increased morbidity and mortality. Central sleep apnea occurs more commonly in heart failure-reduced ejection fraction, and obstructive sleep apnea occurs more frequently in heart failure with preserved ejection fraction. Although the two types of sleep-disordered breathing have distinct pathophysiologic mechanisms, both contribute to abnormal cardiovascular consequences. Treatment with continuous positive airway pressure for obstructive sleep apnea in heart failure has been well defined, whereas treatment strategies for central sleep apnea in heart failure continue to evolve. Unilateral transvenous neurostimulation has shown promise for the treatment of central sleep apnea. In this paper, we examine the current state of knowledge of treatment options for sleep-disordered breathing in heart failure.Entities:
Keywords: Sleep-disordered breathing; central sleep apnea; heart failure; obstructive sleep apnea; sleep apnea
Year: 2017 PMID: 29387467 PMCID: PMC5739888 DOI: 10.15420/cfr.2017:7:1
Source DB: PubMed Journal: Card Fail Rev ISSN: 2057-7540